Wilsele, Belgium

Henryk S Taper


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Henryk S Taper

Introduction

Henryk S Taper is a notable inventor based in Wilsele, Belgium. He has made significant contributions to the field of cancer treatment through his innovative patent. His work focuses on the combination of Vitamin C and a quinone, which serves as a supplemental treatment for cancer patients.

Latest Patents

Henryk S Taper holds 1 patent that details a method for using a combination of Vitamin C and a quinone. This combination can be administered before, during, and after conventional cancer treatment protocols. The treatment can be given orally, intravenously, or intraperitoneally. Oral administration may involve capsules containing a specific ratio of Vitamin C to Vitamin K. This innovative approach aims to inhibit metastases of cancer cells and tumor growth. The effective ratio of Vitamin C to Vitamin K ranges from about 50 to 1 to about 250 to 1. Additionally, a method for evaluating the treatment's effectiveness includes monitoring the patient's serum DNase activity throughout the treatment course.

Career Highlights

Henryk S Taper is associated with Summa Health System, where he continues to contribute to advancements in medical treatments. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Henryk has collaborated with notable colleagues, including Jacques Gilloteaux and James M Jamison. Their combined expertise enhances the research and development of effective cancer treatments.

Conclusion

Henryk S Taper's innovative approach to cancer treatment through his patent demonstrates the potential of combining established compounds for enhanced therapeutic effects. His contributions are paving the way for new treatment protocols that may significantly benefit cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…